A novel adenosine analog, AMP579, inhibits neutrophil activation, adherence and neutrophil-mediated injury to coronary vascular endothelium

By Nakamura M.   Zhao Z.-Q.   Clark K.L.   Velez D.V.   Guyton R.A.   Vinten-Johansen J.  

European Journal of Pharmacology, Vol. 397, Iss. 1, 2000-05 ,pp. : 197-205

Elsevier

Access to resources Recommend Favorite

The vascular endothelium in diabetes: a practical target fordrug treatment?

By Andrews Karen L   Pannirselvam Malarvannan   Anderson Todd J   Jenkins Alicia J   Triggle Chris R   Hill Michael A  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 1, 2005-02 ,pp. : 101-117

Informa Healthcare

Access to resources Recommend Favorite

The endothelium: influencing vascular smooth muscle in many ways

By Triggle Chris R.   Samuel Samson Mathews   Ravishankar Shalini   Marei Isra   Arunachalam Gnanapragasam   Ding Hong  

Canadian Journal of Physiology and Pharmacology, Vol. 90, Iss. 6, 2012-06 ,pp. : 713-738

NRC Research Press

Access to resources Recommend Favorite

Endothelium-dependent hyperpolarization: a role in the control of vascular tone

By Garland C.J.   Plane F.   Kemp B.K.   Cocks T.M.  

Trends in Pharmacological Sciences, Vol. 16, Iss. 1, 1995-01 ,pp. : 23-30

Elsevier

Access to resources Recommend Favorite

Vascular endothelium: target or victim of cytostatic therapy?

By Romanov Yuri A.   Chervontseva Alevtina M.   Savchenko Valery G.   Smirnov Vladimir N.  

Canadian Journal of Physiology and Pharmacology, Vol. 85, Iss. 3-4, 2007-03 ,pp. : 396-403

NRC Research Press

Access to resources Recommend Favorite